ArticleBiological trace element research2025
Kolaviron: a Bioflavonoid from Seed Extract of Garcinia kola Attenuates Chromium (VI)-Induced Gut Dysfunction and Oxidative Damage in Drosophila melanogaster.
Article in Biological trace element research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Traditional use of Garcinia kola Heckel in Nigeria - the results of questionnaire survey compared with scientific evidence.BMC complementary medicine and therapies · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hexavalent chromium [Cr(VI)] is of public health significance due to its toxicity and carcinogenic effects. Kolaviron, a bio-flavonoid fraction from Garcinia kola seed, has been reported to possess gastroprotective and antioxidative properties. We hypothesize that Kolaviron-fortified diet will attenuate chromium (VI)-induced gut dysfunction and oxidative damage in Drosophila melanogaster. We exposed D. melanogaster (Oregon strain of 1-3 days old of both male and female) to a 1.0 mg/kg diet of chromium (VI), with or without Kolaviron (100 mg/kg diet) orally for 5 days. We evaluated markers of oxidative stress (total peroxide and protein carbonyl), antioxidative status (total thiols (T-SH), non-protein thiols (NP-SH), and catalase), and inflammatory (nitric oxide (nitrite and nitrate) and gut's morphology. The data indicated that Kolaviron ameliorated chromium (VI)-induced reduction in the levels of T-SH, NP-SH, and catalase activity (p < 0.05). In addition, Kolaviron attenuated chromium (VI)-induced elevation of total peroxide, protein carbonyl, and nitric oxide (p < 0.05). Kolaviron offered a protective role in chromium VI-induced toxicity in the gut of D. melanogaster. This study provided further insights into the protective mechanisms of Kolaviron against chromium (VI)-induced toxicity in D. melanogaster by maintaining epithelial integrity of the gut and oxidative stress-antioxidant balance.
Indexed as
Identifiers
39425879What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.